REPORT OF THE 6 TH GAELF MEETING, JUNE 2010 References 1. Cheun H-II, Kong Y, Cho S-H, Lee J-S, Chai J-Y, Lee J-S, Lee J-K, Kim T-S: Successful control of lymphatic filariasis in the Republic of Korea. Korean J Parasi<strong>to</strong>l 2009, 47:323- 335. 2. Cheun H-II, J-S, Lee, Cho S-H, Kong Y, Kim T-S: Elimination of lymphatic filariasis in the Republic of Korea: an epidemiological survey of formerly endemic areas, 2002-2006. Trop Med Internat Health 2009, 14:445-449. 3. Ottesen EA, Hooper PJ, Bradley M, Biswas G: The global programme <strong>to</strong> eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 2008, Oct 8;2(10):e317. 4. Chu BK, Hooper PJ, Bradley MH, McFarland DA, Ottesen EA: The economic benefits resulting from the first 8 years of the <strong>Global</strong> Programme <strong>to</strong> <strong>Eliminate</strong> <strong>Lymphatic</strong> <strong>Filariasis</strong> (2000-2007). PLoS Negl Trop Dis 2010, 4(6):e708. 5. Shenoy RK, Suma TK, Kumaraswami V, Rahmah N, Dhananjayan G, Padma S: Antifilarial drugs, in the doses employed in mass drug administrations by the <strong>Global</strong> Programme <strong>to</strong> <strong>Eliminate</strong> <strong>Lymphatic</strong> <strong>Filariasis</strong>, reverse lymphatic pathology in children with Brugia malayi infection. Ann Trop Med Parasi<strong>to</strong>l 2009, 103:235-247. 6. Narahari SR, Ryan TJ, Mahadevan PE et al.: Integrated management of filarial lymphoedema for rural communities. Lymphology 2007, 40:3-13. 7. Narahari SR, Aggithaya GM, Bose KS, Prasanna KS: An Integrative Treatment for Lower Limb Lymphoedema (Elephantiasis) (pho<strong>to</strong> essay). J Alt Compl Medicine 2010, 16: 145- 149. 8. Ramzy RM, El Se<strong>to</strong>uhy M, Helmy H, Ahmed ES, Abd Elaziz KM, Farid HA, Shannon WD, Weil GJ: Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 2006, 367:992-999. 9. El-Se<strong>to</strong>uhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, Ramzy RM, Shannon WD, Weil GJ: The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. Am J Trop Med Hyg 2007, 77:1069-1073. 10. Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Larbi J, Lawson B, Taylor M, Adjei O, Hoerauf A: Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2006, 2:e92. 11. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Lawson B, Taylor M, Adjei O, Hoerauf A. Reduction in levels of plasma vascular endothelial growth fac<strong>to</strong>r-A and 52
REPORT OF THE 6 TH GAELF MEETING, JUNE 2010 improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline. Am J Trop Med Hyg 2009, 80:956-963. 12. Wanji S, Tendongfor N, Nji T, Esum M, Che JN, Nkwescheu A, Alassa F, Kamnang G, Enyong PA, Taylor MJ, Hoerauf A, Taylor DW: Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon. Parasit Vec<strong>to</strong>rs 2009, 2:39. 13. Bockarie MJ, Pedersen EM, White GB, Michael E: Role of vec<strong>to</strong>r control in the global program <strong>to</strong> eliminate lymphatic filariasis. Annu Rev En<strong>to</strong>mol 2009, 54:469-487. 14. Liese B, Schubert L: Official development assistance for health—how neglected are neglected tropical diseases? An analysis of health financing. Int Health 2009, 1:141– 147. 53
- Page 1 and 2: Half-time in LF Elimination: Teamin
- Page 3 and 4: REPORT OF THE 6 TH GAELF MEETING, J
- Page 5 and 6: REPORT OF THE 6 TH GAELF MEETING, J
- Page 7 and 8: REPORT OF THE 6 TH GAELF MEETING, J
- Page 9 and 10: REPORT OF THE 6 TH GAELF MEETING, J
- Page 11 and 12: REPORT OF THE 6 TH GAELF MEETING, J
- Page 13 and 14: REPORT OF THE 6 TH GAELF MEETING, J
- Page 15 and 16: REPORT OF THE 6 TH GAELF MEETING, J
- Page 17 and 18: REPORT OF THE 6 TH GAELF MEETING, J
- Page 19 and 20: REPORT OF THE 6 TH GAELF MEETING, J
- Page 21 and 22: REPORT OF THE 6 TH GAELF MEETING, J
- Page 23 and 24: REPORT OF THE 6 TH GAELF MEETING, J
- Page 25 and 26: REPORT OF THE 6 TH GAELF MEETING, J
- Page 27 and 28: REPORT OF THE 6 TH GAELF MEETING, J
- Page 29 and 30: REPORT OF THE 6 TH GAELF MEETING, J
- Page 31 and 32: REPORT OF THE 6 TH GAELF MEETING, J
- Page 33 and 34: REPORT OF THE 6 TH GAELF MEETING, J
- Page 35 and 36: REPORT OF THE 6 TH GAELF MEETING, J
- Page 37 and 38: REPORT OF THE 6 TH GAELF MEETING, J
- Page 39 and 40: REPORT OF THE 6 TH GAELF MEETING, J
- Page 41 and 42: REPORT OF THE 6 TH GAELF MEETING, J
- Page 43 and 44: REPORT OF THE 6 TH GAELF MEETING, J
- Page 45 and 46: REPORT OF THE 6 TH GAELF MEETING, J
- Page 47 and 48: REPORT OF THE 6 TH GAELF MEETING, J
- Page 49 and 50: REPORT OF THE 6 TH GAELF MEETING, J
- Page 51: REPORT OF THE 6 TH GAELF MEETING, J
- Page 55 and 56: REPORT OF THE 6 TH GAELF MEETING, J
- Page 57 and 58: REPORT OF THE 6 TH GAELF MEETING, J
- Page 59 and 60: REPORT OF THE 6 TH GAELF MEETING, J
- Page 61 and 62: REPORT OF THE 6 TH GAELF MEETING, J
- Page 63 and 64: REPORT OF THE 6 TH GAELF MEETING, J
- Page 65 and 66: REPORT OF THE 6 TH GAELF MEETING, J
- Page 67 and 68: REPORT OF THE 6 TH GAELF MEETING, J
- Page 69: REPORT OF THE 6 TH GAELF MEETING, J
Change language